Lattice Biologics Ltd. (LBLTF)

Overview

Lattice Biologics Ltd. is a pioneering biotech enterprise dedicated to developing, manufacturing, and marketing advanced biologics products globally. Founded in 2013 and based in Belgrade, Montana, the company has established itself as a niche player in the field of bone regeneration, catering to dental, spine, and general orthopedic indications. Its focus on leveraging innovative biotechnologies to create effective solutions for complex medical needs places it at the forefront of regenerative medicine.

Products and Services

Acellular Demineralized Bone Scaffold: This product is at the heart of Lattice Biologics’ portfolio, featuring human cortical bone that has been demineralized to serve as a versatile scaffold in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures. Its application is widespread, offering a foundation for the regeneration of healthy bone tissue.

Acellular Dermal Matrix: Lattice Biologics develops this innovative product which acts as a natural collagen tissue scaffold. It is designed to promote cellular ingrowth, tissue vascularization, and regeneration. This matrix is an integral component in various surgical repairs and reconstructions, facilitating healing in a natural and effective manner.

Amniotic Fluid-Based Products: The company's line of amniotic fluid-based products, including AmnioBoost and AmnioBlast, represents a significant advancement in regenerative medicine. These products harness the natural healing and anti-inflammatory properties of amniotic fluid, offering therapeutic benefits for a variety of medical applications.

Traditional Allografts: In addition to its specialized biologics products, Lattice Biologics also supplies traditional allografts. These biological grafts are used in multiple disciplines such as orthopedics, neurology, podiatry, and oral/maxillofacial surgeries. Allografts are pivotal in various therapeutic applications, aiding in tissue repair and regeneration.